{"symbol": "TOCA", "companyName": "Tocagen Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.tocagen.com", "description": "Tocagen Inc is a clinical-stage, cancer-selective gene therapy company focused on developing product candidates designed to activate a patient's immune system against cancer from within. Its pipeline product includes Toca 511 and Toca FC.", "CEO": "Martin J. Duvall", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}